BioNTech SE (BNTX) Times Interest Earned (2018 - 2025)
BioNTech SE (BNTX) posted Times Interest Earned of $76.86 for Q4 2025, up 4029.64% sequentially from $1.86 in Q3 2025, and up 751.68% YoY from $9.02 in Q4 2024.
BioNTech SE (BNTX) Times Interest Earned (2018 - 2025) Analysis & Trends
BioNTech SE has reported Times Interest Earned for 8 years, with the latest figure at $76.86 in Q4 2025.
- Quarterly Times Interest Earned rose 751.68% year-over-year to $76.86 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.01 (down 50.41% YoY) and the FY2025 annual result came in at -$20.13, up 58.04% from the prior year.
- Times Interest Earned advanced to $76.86 in Q4 2025 per BNTX's latest filing, from $1.86 in the prior quarter.
- Over five years, Times Interest Earned peaked at $433.31 in Q2 2023 and troughed at -$819.43 in Q2 2022.
- A 5-year average of -$82.31 and a median of -$0.66 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned tumbled 2686283.81% in 2022, then surged 751.68% in 2025.
- Over 5 years, Times Interest Earned stood at -$0.0 in 2021, then sank by 2686283.81% to -$20.7 in 2022, then fell by 0.89% to -$20.88 in 2023, then jumped by 43.52% to -$11.79 in 2024, then soared by 751.68% to $76.86 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered $76.86, $1.86, and $71.59 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 4.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.86 |
| Sep 30, 2025 | 1.86 |
| Jun 30, 2025 | 71.59 |
| Mar 31, 2025 | 15.76 |
| Dec 31, 2024 | -11.79 |
| Sep 30, 2024 | -1.31 |
| Jun 30, 2024 | 132.36 |
| Mar 31, 2024 | 107.91 |
| Dec 31, 2023 | -20.88 |
| Sep 30, 2023 | -36.55 |
| Jun 30, 2023 | 433.31 |
| Mar 31, 2023 | -22.57 |
| Dec 31, 2022 | -20.70 |
| Sep 30, 2022 | -742.14 |
| Jun 30, 2022 | -819.43 |
| Mar 31, 2022 | -814.49 |
| Dec 31, 2021 | -770.44 |
| Sep 30, 2021 | -57.12 |
| Jun 30, 2021 | 23.87 |
| Mar 31, 2021 | 37.19 |